A new foundation run by Wojcicki's family is searching for answers about why more nonsmokers are getting lung cancer.

Texas A&M Baseball has partnered with the Mark Massey Legacy Foundation to launch the “Strikeout DMG” initiative during Brain ...

Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells. On Tuesday, researchers said a single dose of those revved-up cells ...

A PRIMARY school teacher who thought she had IBS was shocked when a test revealed she had stage three cancer – and she’s ...

A Manitoba man with a highly aggressive type of brain cancer says an expensive treatment device has bought him more quality ...

The Princess of Wales is "energised" and "enthused" for her first overseas visit since her cancer treatment, a royal aide has claimed. Catherine is embarking on her first official overseas engagement ...

This Magic Round, the Broncos will join forces with all 17 NRL clubs, more than 50,000 fans and hundreds of players as the ...

Top-line data from the Phase 3 OPERA-01 trial anticipated this fall; Phase 3 OPERA-02 trial continues to enroll patientsFirst clinical data from OP-3136 Phase 1 study to be presented at ASCO Ended the ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

As blood stem cells age, their lysosomes become overactive and damaged, triggering inflammation and weakening the body’s ...

Andrea Brault is fighting acute myeloid leukemia and needs a bone marrow transplant. But finding a donor match can be more ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.